by telrheum | Apr 6, 2024 | Biologic Therapy, Rheumatic Drugs, Rheumatoid Arthritis
The ARCTIC REWIND study explored the long-term effects of reducing and stopping tumor necrosis factor inhibitor (TNFi) treatment in patients with rheumatoid arthritis (RA) who were in sustained remission. The study involved randomly assigning patients who had been in...
by telrheum | Apr 1, 2024 | Magnetic Resonance Imaging, Rheumatoid Arthritis, Uncategorized
The study explored the effectiveness and safety of auricular vagus nerve stimulation (VNS) in treating rheumatoid arthritis (RA). Earlier small or uncontrolled studies suggested VNS could reduce RA symptoms. In this larger, controlled trial, participants with active...
by telrheum | Mar 31, 2024 | Biologic Therapy, Magnetic Resonance Imaging, Psoriatic Arthritis
The article discusses a study on how tumor necrosis factor-alpha (TNFα) inhibition, a treatment for psoriatic arthritis (PsA), affects pain processing in the brain, using functional magnetic resonance imaging (fMRI). The study included 6 PsA patients, some new to...
by telrheum | Mar 31, 2024 | Psoriasis, Psoriatic Arthritis, Spondyloarthritis
Hemay005 is an experimental drug being tested for its ability to treat chronic inflammatory diseases like psoriasis by inhibiting a specific enzyme, PDE4, which plays a key role in the inflammation process. The drug aims to reduce the activity of T lymphocytes and...
by telrheum | Mar 30, 2024 | Radiology, Magnetic Resonance Imaging, Spondyloarthritis
In this study, researchers focused on leveraging deep learning technology to enhance the diagnosis of axial spondyloarthritis (SpA), specifically by detecting active spinal inflammation through MRI scans. A total of 330 patients diagnosed with axial SpA were involved...
